Additionally, the 36-month beta value for ALHC is 1.24. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 1 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for ALHC is 110.10M and currently, short sellers hold a 9.44% ratio of that float. The average trading volume of ALHC on May 13, 2025 was 3.14M shares.
ALHC) stock’s latest price update
The stock price of Alignment Healthcare Inc (NASDAQ: ALHC) has dropped by -7.44 compared to previous close of 14.92. Despite this, the company has seen a fall of -12.15% in its stock price over the last five trading days. seekingalpha.com reported 2025-05-02 that Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q1 2025 Earnings Conference Call May 1, 2025 5:00 PM ET Company Participants John Kao – Founder and CEO Thomas Freeman – Chief Financial Officer Conference Call Participants Ryan Daniels – William Blair Michael Ha – Baird John Ransom – Raymond James Whit Mayo – Leerink Partners Jessica Tassan – Piper Sandler Joanna Gajuk – Bank of America Matthew Gillmor – KeyBanc Jonathan Yong – UBS Ryan Langston – TD Cowen Andrew Mok – Barclays Operator Good afternoon, and welcome to Alignment Healthcare’s First Quarter 2025 Earnings Conference Call and Webcast. At this time, all participants are in a listen-only mode.
ALHC’s Market Performance
ALHC’s stock has fallen by -12.15% in the past week, with a monthly drop of -30.04% and a quarterly drop of -3.96%. The volatility ratio for the week is 3.35% while the volatility levels for the last 30 days are 5.47% for Alignment Healthcare Inc The simple moving average for the past 20 days is -18.24% for ALHC’s stock, with a 5.73% simple moving average for the past 200 days.
Analysts’ Opinion of ALHC
Many brokerage firms have already submitted their reports for ALHC stocks, with Stephens repeating the rating for ALHC by listing it as a “Overweight.” The predicted price for ALHC in the upcoming period, according to Stephens is $17 based on the research report published on December 03, 2024 of the previous year 2024.
BofA Securities gave a rating of “Buy” to ALHC, setting the target price at $11 in the report published on May 30th of the previous year.
ALHC Trading at -19.33% from the 50-Day Moving Average
After a stumble in the market that brought ALHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.43% of loss for the given period.
Volatility was left at 5.47%, however, over the last 30 days, the volatility rate increased by 3.35%, as shares sank -27.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.02% lower at present.
During the last 5 trading sessions, ALHC fell by -12.15%, which changed the moving average for the period of 200-days by +47.54% in comparison to the 20-day moving average, which settled at $16.89. In addition, Alignment Healthcare Inc saw 22.76% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALHC starting from JOYCE CHRISTOPHER J, who sale 25,000 shares at the price of $16.87 back on May 01 ’25. After this action, JOYCE CHRISTOPHER J now owns 390,022 shares of Alignment Healthcare Inc, valued at $421,828 using the latest closing price.
CHRISTOPHER JOYCE, the Officer of Alignment Healthcare Inc, proposed sale 40,491 shares at $17.72 during a trade that took place back on May 01 ’25, which means that CHRISTOPHER JOYCE is holding shares at $717,501 based on the most recent closing price.
Stock Fundamentals for ALHC
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.12 for the gross margin
The net margin for Alignment Healthcare Inc stands at -0.03. The total capital return value is set at -0.15. Equity return is now at value -75.82, with -11.86 for asset returns.
Based on Alignment Healthcare Inc (ALHC), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at 7.53. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is -2.98.
Currently, EBITDA for the company is -77.59 million with net debt to EBITDA at 10.9. When we switch over and look at the enterprise to sales, we see a ratio of 0.76. The receivables turnover for the company is 14.02for trailing twelve months and the total asset turnover is 3.35. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.69.
Conclusion
In conclusion, Alignment Healthcare Inc (ALHC) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
